CDI study identifies how p53 mutations drive immunotherapy resistance—and a path to overcome it
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
CDI study identifies how p53 mutations drive immunotherapy resistance—and a path to overcome it
New approach targeting deadliest brain cancer shows promise in early testing
Natural compounds against sarcoma. Which shows the greatest potential?
New AI-guided technique may improve delivery of brain tumour therapy
Researchers find new strategy to help immune system fight pancreatic cancer
Researchers identify druggable target that makes metastatic cancer cells easier to kill
Beyond the treadmill: reframing exercise oncology as a discovery engine for cancer therapy
Microneedles may help light reach hard-to-treat skin cancers
Blood vessels guide immune cells to metastases
Clinical trial finds oral drug keeps cancer treatment on track for patients who develop persistently low platelet counts
FDA grants traditional approval to selpercatinib for locally advanced or metastatic RET fusion-positive solid tumours
ENDURANCE trial shows no survival benefit for extended lenalidomide maintenance in Multiple Myeloma